Literature DB >> 1372649

Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells.

P Vandenberghe1, G J Freeman, L M Nadler, M C Fletcher, M Kamoun, L A Turka, J A Ledbetter, C B Thompson, C H June.   

Abstract

CD28 is an adhesion receptor expressed as a 44-kD dimer on the surface of a major subset of human T cells. The CD28 receptor regulates the production of multiple lymphokines, including interleukin 2 (IL-2), by activation of a signal transduction pathway that is poorly understood. Here we show that ligation of CD28 by a monoclonal antibody (mAb) or by a natural ligand, B7/BB1, induces protein tyrosine phosphorylation that is distinct from T cell receptor (TCR)-induced tyrosine phosphorylation. CD28-induced protein tyrosine phosphorylation was greatly enhanced in cells that had been preactivated by ligation of the TCR, or by pretreatment with phorbol esters. Rapid and prolonged tyrosine phosphorylation of a single substrate, pp100, was induced in T cells after interaction with B7/BB1 presented on transfected Chinese hamster ovary (CHO) cells. Anti-B7 mAb inhibited B7/BB1 receptor-induced tyrosine phosphorylation, indicating that B7-CD28 interaction was required. CD28-induced tyrosine phosphorylation was independent of the TCR because it occurred in a variant of the Jurkat T cell line that does not express the TCR. Herbimycin A, a protein tyrosine kinase inhibitor, could prevent CD28-induced tyrosine phosphorylation and CD28-induced IL-2 production in normal T cells. The simultaneous crosslinking of CD28 and CD45, a tyrosine phosphatase, could prevent tyrosine phosphorylation of pp100. These results suggest that specific tyrosine phosphorylation, particularly of pp100, occurs directly as a result of CD28 ligand binding and is involved in transducing the signal delivered through CD28 by accessory cells that express the B7/BB1 receptor. Thus, this particular form of signal transduction may be relevant to lymphokine production and, potentially may provide a means to study the induction of self-tolerance, given the putative role of the costimulatory signal in the induction of T cell activation or anergy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372649      PMCID: PMC2119170          DOI: 10.1084/jem.175.4.951

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production.

Authors:  G A Koretzky; J Picus; T Schultz; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

2.  B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2.

Authors:  C D Gimmi; G J Freeman; J G Gribben; K Sugita; A S Freedman; C Morimoto; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

Review 3.  Signals arising from antigen-presenting cells.

Authors:  R M Steinman; J W Young
Journal:  Curr Opin Immunol       Date:  1991-06       Impact factor: 7.486

4.  Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.

Authors:  C H June; M C Fletcher; J A Ledbetter; L E Samelson
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

Review 5.  Role of lymphokine and antigen in the control of specific T cell responses.

Authors:  K J Lafferty; L Andrus; S J Prowse
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

6.  T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation.

Authors:  W Lesslauer; F Koning; T Ottenhoff; M Giphart; E Goulmy; J J van Rood
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

7.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28.

Authors:  J D Fraser; B A Irving; G R Crabtree; A Weiss
Journal:  Science       Date:  1991-01-18       Impact factor: 47.728

8.  B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.

Authors:  T Yokochi; R D Holly; E A Clark
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

9.  The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.

Authors:  L Koulova; E A Clark; G Shu; B Dupont
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

10.  Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen).

Authors:  T Hara; S M Fu; J A Hansen
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  30 in total

1.  T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.

Authors:  L A Turka; P S Linsley; H Lin; W Brady; J M Leiden; R Q Wei; M L Gibson; X G Zheng; S Myrdal; D Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

Review 2.  Recent advances and discoveries in the mechanisms and functions of CAR T cells.

Authors:  Rebecca C Larson; Marcela V Maus
Journal:  Nat Rev Cancer       Date:  2021-01-22       Impact factor: 60.716

Review 3.  Genetic engineering of T cells for adoptive immunotherapy.

Authors:  Angel Varela-Rohena; Carmine Carpenito; Elena E Perez; Max Richardson; Richard V Parry; Michael Milone; John Scholler; Xueli Hao; Angela Mexas; Richard G Carroll; Carl H June; James L Riley
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

4.  Activation-dependent phosphorylation of the T-lymphocyte surface receptor CD28 and associated proteins.

Authors:  J E Hutchcroft; B E Bierer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

5.  B7/CD28 but not LFA-3/CD2 interactions can provide 'third-party' co-stimulation for human T-cell activation.

Authors:  D M Sansom; A Wilson; M Boshell; J Lewis; N D Hall
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 6.  Modulation of T cell proliferative response by accessory cell interactions.

Authors:  J M Green; C B Thompson
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Effect of CD28 signal transduction on c-Rel in human peripheral blood T cells.

Authors:  R G Bryan; Y Li; J H Lai; M Van; N R Rice; R R Rich; T H Tan
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  Signalling through CD28 T-cell activation pathway involves an inositol phospholipid-specific phospholipase C activity.

Authors:  J Nunes; S Klasen; M D Franco; C Lipcey; C Mawas; M Bagnasco; D Olive
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

10.  itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.

Authors:  J D Siliciano; T A Morrow; S V Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.